This Framework of indicators and targets for laboratory strengthening under the End TB Strategy serves as a guide for all countries developing plans for laboratory strengthening during 2016–2025.
The World Health Organization’s (WHO’s) End TB Strategy calls for the early diagnosis of tuberculosis (TB) including universal drug-susceptibility testing (DST). A prerequisite for any national TB programme to reach this goal is a quality-assured laboratory network equipped with rapid diagnostics.
This Framework of indicators and targets for laboratory strengthening under the End TB Strategy serves as a guide for all countries developing plans for laboratory strengthening during 2016–2025. The indicators measure programmes’ capacity to detect TB accurately and rapidly using new diagnostics (known as WHO-recommended rapid diagnostics, or WRDs), provide universal DST, and ensure the quality of testing.
